$CBRS

Vassallo Steven sold $10.9M of CBRS (indirect holdings)

Vassallo Steven sold 50,000 indirectly-held shares of Cerebras Systems Inc. (CBRS) at an average of $218.18 ($216.38–$219.97, $10.91M total) across 5 trades on 2026-08-14.

Original reporting
SEC EDGAR · Vassallo Steven
Published Aug 18, 2026, 10:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 18, 2026, 11:06 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CBRS
Neutral
medium confidence
Mentioned
$CBRS
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CBRSNeutralLow
01

Why it matters

The newest fact is the disclosed sale size, execution dates, price range, and post-transaction holdings for a director, which can marginally affect sentiment but not fundamentals.

02

Market read

Traders may monitor for follow-on insider activity, but this filing alone is unlikely to drive a sustained repricing.

03

What to watch

The filing notes indirect holdings and no 10b5-1 plan, but it does not disclose the reason for sale or whether other insiders are trading, limiting inference.

Relevance 7/10Novelty 3/10Timing: filed Aug. 18, covering sales executed Aug. 14

Background

The article is an SEC Form 4 insider transaction disclosure for Cerebras Systems Inc. (CBRS).

Company-level read

Ticker impact

$CBRSNeutralMedium confidence
Context

Cerebras Systems director Vassallo Steven sold about $10.9M of CBRS shares via an open-market sale across five trades on Aug. 14.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and should fade unless followed by additional disclosures.

Evidence & confidence

Form 4 provides transaction details (size, dates, prices) but no new company-specific operating or guidance information. Absence of a 10b5-1 plan can raise scrutiny, yet insider sales are common and not automatically bearish.

Market effects

No clear sector read-through from a single director sale without accompanying company news.

None indicated.

None indicated.

Counterpoint

The sale could be for diversification or liquidity needs and may not reflect negative expectations, especially given the multi-trade execution window.

Key entities

  • Cerebras Systems Inc.

    CBRS, the company whose director sold shares as reported on Form 4.

  • Vassallo Steven

    Director who reported an open-market sale of CBRS shares totaling about $10.9M.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CBRSMed

Cerebras stock jumps 9%; Q3 sales guide sets a harder test

Cerebras Systems (CBRS) stock rose 9% after OpenAI's Sam Altman reaffirmed their partnership. The company's Q3 revenue guidance suggests 2.4% sequential growth. OpenAI committed to 750MW of capacity, with an option for 1.25GW. Cerebras reported $56.8M in OpenAI-related revenue in Q2, 31.5% of total GAAP revenue. The stock remains below its IPO price of $185.

$CBRSHigh

CBRS Stock Surges Over 6% in Monday Pre-Market: What's the Sam Altman Connection? - Cerebras Systems (NAS

Cerebras Systems (CBRS) shares rose 6.56% premarket after OpenAI CEO Sam Altman called it a 'close partner,' easing concerns. Analysts noted strong ties with OpenAI, despite Nvidia (NVDA) running its new model. Barclays' Tom O'Malley called the sell-off 'overdone,' while Paul Meeks upgraded CBRS to Buy with a $209 target, citing high AI demand. CBRS is down 52.45% YTD.

$CBRSMed

Mizuho reiterates Cerebras Systems stock rating on inference growth

Mizuho reiterated its Outperform rating and $300 price target for Cerebras Systems (CBRS), citing growth in fast inference workloads. The firm projects a $550B market by 2030, with CBRS trading near its 52-week low at $166.43. CBRS reported 91% revenue growth over the last year, and analysts have revised earnings upwards, though some suggest overvaluation. The company unveiled the CS-4 system, with improved performance and compute density, expected in Q3.